114 related articles for article (PubMed ID: 2373667)
1. Oral pefloxacin mesylate in the treatment of continuous ambulatory peritoneal dialysis associated peritonitis: an open non-comparative study.
Rose TF; Ellis-Pegler R; Collins J; Small M
J Antimicrob Chemother; 1990 May; 25(5):853-9. PubMed ID: 2373667
[TBL] [Abstract][Full Text] [Related]
2. Oral pefloxacin in the treatment of CAPD peritonitis.
Tan HW; Kon SP; Chua CT; Ngeow NF
Med J Malaysia; 1992 Jun; 47(2):128-33. PubMed ID: 1494333
[TBL] [Abstract][Full Text] [Related]
3. Plasma and dialysate levels of pefloxacin and its metabolites in CAPD patients with peritonitis.
Rose TF; Bremner DA; Collins J; Ellis-Pegler R; Isaacs R; Richardson R; Small M
J Antimicrob Chemother; 1990 Apr; 25(4):657-64. PubMed ID: 2351626
[TBL] [Abstract][Full Text] [Related]
4. Peritonitis during continuous ambulatory peritoneal dialysis. Treatment with pefloxacin: first results and pharmacokinetics.
Benzakour M; Lagarde C; Benevent D; Mounier M; Denis F
Nephron; 1988; 50(2):175-6. PubMed ID: 3065665
[No Abstract] [Full Text] [Related]
5. Management of peritonitis related to chronic ambulatory peritoneal dialysis (CAPD) using two daily intraperitoneal injections of 400 mg pefloxacin.
Ragnaud JM; Roche-Bezian MC; Dupon M; Wone C
Chemioterapia; 1987 Jun; 6(2 Suppl):481-3. PubMed ID: 3509476
[No Abstract] [Full Text] [Related]
6. [Treatment of peritonitis in kidney failure patients under continuous ambulatory peritoneal dialysis by pefloxacine. Results and pharmacokinetics].
Denis F; Mounier M; Lagarde C; Benevent D
Pathol Biol (Paris); 1987 May; 35(5):652-5. PubMed ID: 3302879
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of peritonitis in continuous ambulatory peritoneal dialysis with a combination of fosfomycin and pefloxacin].
Michel C; Viron B; Delisle F; Lependoven C; Mignon F
Pathol Biol (Paris); 1989 Apr; 37(4):269-71. PubMed ID: 2660079
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis.
Lye WC; Lee EJ; van der Straaten J
Perit Dial Int; 1993; 13 Suppl 2():S348-50. PubMed ID: 8399607
[TBL] [Abstract][Full Text] [Related]
9. Newer quinolones in the treatment of continuous ambulatory peritoneal dialysis (CAPD) related infections.
Nikolaidis P
Perit Dial Int; 1990; 10(2):127-33. PubMed ID: 2085597
[TBL] [Abstract][Full Text] [Related]
10. Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nikolaidis P; Walker SE; Dombros N; Tourkantonis A; Paton TW; Oreopoulos DG
Perit Dial Int; 1991; 11(1):59-63. PubMed ID: 2049424
[TBL] [Abstract][Full Text] [Related]
11. Peritonitis in continuous ambulatory peritoneal dialysis.
Smith WG; Tsakiris DJ; Junor BJ; Briggs JD; Alcock SR; Reading P; Hallam S
Scott Med J; 1986 Apr; 31(2):85-9. PubMed ID: 3738483
[TBL] [Abstract][Full Text] [Related]
12. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
13. Flavobacterial peritonitis in patients treated by peritoneal dialysis.
Korzets Z; Maayan MC; Bernheim J
Nephrol Dial Transplant; 1995; 10(2):280-3. PubMed ID: 7753467
[No Abstract] [Full Text] [Related]
14. A single-centre experience: peritoneal dialysis-related infections in patients on long-term dialysis.
Luvira V; Satirapoj B; Supasyndh O; Chaiprasert A; Ruangkanchanasetr P; Nata N; Kanjanakul I; Supaporn T; Choovichian P; Bijaphala S; Luvira U; Phiboonbanakit D
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S30-6. PubMed ID: 22043564
[TBL] [Abstract][Full Text] [Related]
15. Low dose intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD).
Dryden MS; Wing AJ; Phillips I
J Antimicrob Chemother; 1991 Jul; 28(1):131-9. PubMed ID: 1769932
[TBL] [Abstract][Full Text] [Related]
16. Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Fleming LW; Phillips G; Stewart WK; Scott AC
J Antimicrob Chemother; 1990 Mar; 25(3):441-8. PubMed ID: 2338420
[TBL] [Abstract][Full Text] [Related]
17. CAPD peritonitis and fluoroquinolones: a review.
Janknegt R
Perit Dial Int; 1991; 11(1):48, 53-8. PubMed ID: 2049423
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD).
Ludlam HA; Barton I; White L; McMullin C; King A; Phillips I
J Antimicrob Chemother; 1990 May; 25(5):843-51. PubMed ID: 2197264
[TBL] [Abstract][Full Text] [Related]
19. Treatment of peritonitis in continuous ambulatory peritoneal dialysis patients with co-trimoxazole.
Glasson P; Favre H
Nephron; 1984; 36(1):65-7. PubMed ID: 6606789
[TBL] [Abstract][Full Text] [Related]
20. The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis.
Passadakis P; Oreopoulos D
Adv Perit Dial; 2001; 17():180-90. PubMed ID: 11510271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
